Tempo.co English

The Green Paradox of Ethiopia's Renaissance Dam

Africa's largest hydroelectric plant is a source of national pride, but will Ethiopia's Renaissance Dam truly deliver power ...

ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in ...

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...

ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

AI analyzes world's largest heart attack data sets—and reveals new treatment methods

A landmark international study led by the University of Zurich has shown that artificial intelligence can assess patient risk ...

Scientists Begin $14.2 Million Project To Decode the Body’s “Hidden Sixth Sense”

An NIH-supported initiative seeks to unravel how the nervous system tracks and regulates the body’s internal organs. How does ...